Top brokers name 3 ASX shares to sell next week

Brokers aren't feeling overly positive on these shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were bearish.

Three sell ratings that caught my eye are summarised below. Here's why top brokers think investors ought to sell these shares next week:

Fortescue Metals Group Limited (ASX: FMG)

According to a note out of UBS, its analysts have downgraded this mining giant's shares to a sell rating and cut the price target on them to $15.00. The broker made the move on the belief that iron ore prices will continue to fall in the coming months. UBS suspects that prices could fall to between US$70 and US$80 a tonne. This would weigh on Fortescue's free cash flow and dividends. The Fortescue share price ended the week at $15.27.

Magellan Financial Group Ltd (ASX: MFG)

Another note out of UBS reveals that its analysts have downgraded this fund manager's shares to a sell rating and cut the price target on them materially to $35.00. UBS notes that Fortescue is experiencing fund outflows at a time when its investment performance is lagging and pressure on its higher than average fees is growing. The Magellan share price was fetching $15.27 at Friday's close.

Xero Limited (ASX: XRO)

Analysts at Macquarie have retained their underperform rating and $130.00 price target on this cloud accounting company's shares. This follows news that rival Intuit is acquiring email marketing company Mailchimp. Macquarie is concerned that Intuit could remove Mailchimp from Xero's ecosystem. If it does, it suspects that some subscribers may switch to Intuit's Quickbooks in order to retain access to the app. In addition, it believes the acquisition strengthens Intuit's offering and could support its global expansion. The Xero share price ended the week at $153.34.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Xero. The Motley Fool Australia owns shares of and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A team of people giving the thumbs up sign.
Broker Notes

7 ASX 200 shares upgraded to strong buy ratings

Looking for investment inspiration?

Read more »

Two young male miners wearing red hardhats stand inside a mine and shake hands
Broker Notes

Macquarie tips 23% upside for resurgent ASX 200 copper stock riding the red metal's bull run

Macquarie expects more outperformance from this surging ASX 200 copper stock.

Read more »

A woman pulls her jumper up over her face, hiding.
Energy Shares

Is there a downside ahead for Origin Energy shares?

Here's what the broker expects over the next 12 months.

Read more »

A woman in a red dress holding up a red graph.
Industrials Shares

Macquarie tips more than 60% upside for this ASX All Ords stock

This professional services firm's shares are looking cheap, Macquarie says.

Read more »

Happy young woman saving money in a piggy bank.
Broker Notes

Are Westpac shares a buy following the bank's $7 billion FY25 profit result? Here's Macquarie's recommendation

Macquarie just updated its price target for Westpac shares. Here’s why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Macquarie is tipping a 30% return for Resmed shares

This blue chip gets a big thumbs up from analysts at Macquarie.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Broker Notes

Why DroneShield shares could rise 38%

Bell Potter thinks this growth stock could be a top buy this month.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Broker Notes

Expert sees 34% upside potential for CSL shares despite ongoing challenges

Better times ahead?

Read more »